Roundtable Discussion: Identifying Solutions to The Challenges of Solid Tumors

  • CAR-T development for solid tumours has been more challenging than expected
  • With the experience of multiple CAR-T trials what have emerged as the main bottlenecks?
  • What are the most promising solutions and what comes next?